Cargando…

Paradoxical Cardiorenal Responses Following Acute Vasodilator/Natriuretic Treatment in Presystolic Heart Failure: Should We Be Surprised?

Detalles Bibliográficos
Autores principales:	Polonsky, Tamar S., Bakris, George L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938987/ https://www.ncbi.nlm.nih.gov/pubmed/31909769 http://dx.doi.org/10.1016/j.jacbts.2019.11.002

Ejemplares similares

Presystolic Murmur
Publicado: (1889)

On the Presystolic Murmur
por: Cowan, John M.
Publicado: (1898)

Should We Be Ablating the Kidneys or the Heart to Prevent Arrhythmias?
por: Wilson, Lance D., et al.
Publicado: (2017)

When failure should be the option
por: Petsko, Gregory A
Publicado: (2010)

Should we splint traumatised primary teeth?
por: Deery, Chris
Publicado: (2023)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Clinical Lectures on Circulatory Affections: Lecture II. The Cause of the Presystolic Murmur
por: Gibson, G. A.
Publicado: (1900)

The upcoming flu seasons: how worried should we be?
por: Kayali, Ghazi
Publicado: (2022)

Vasodilators in the treatment of acute heart failure: what we know, what we don’t
por: Metra, Marco, et al.
Publicado: (2008)

Should we worry about the accumulation of microplastics in human organs?
por: Sorci, Gabriele, et al.
Publicado: (2022)

Cardiorenal biomarkers in acute heart failure
por: Choudhary, Rajiv, et al.
Publicado: (2012)

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

COVID-19 and Kawasaki syndrome: should we really be surprised?
por: Loomba, Rohit S., et al.
Publicado: (2020)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

Cardiorenal Syndrome in Acute Heart Failure Syndromes
por: Sarraf, Mohammad, et al.
Publicado: (2011)

Genomic testing for rare disease diagnosis—where are we now, and where should we be heading? The reflections of a behavioural scientist
por: Lewis, Celine
Publicado: (2023)

Open questions: why should we care about ER-phagy and ER remodelling?
por: Dikic, Ivan
Publicado: (2018)

Brain natriuretic peptide is a potent vasodilator in aged human microcirculation and shows a blunted response in heart failure patients
por: Edvinsson, Marie-Louise, et al.
Publicado: (2014)

Estimation of glomerular filtration rate in cardiorenal patients: a step forward
por: Quiroga, Borja, et al.
Publicado: (2023)

How should we interpret estimates of individual repeatability?
por: Wilson, Alastair J.
Publicado: (2018)

Renal denervation revisited; should we pay attention?
por: de Winter, R. J.
Publicado: (2022)

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
por: Reuben, Rine Christopher, et al.
Publicado: (2021)

The sustainability paradox of processing plant proteins
por: Duque-Estrada, Patrícia, et al.
Publicado: (2023)

Role of Vasodilator Therapy in Acute Heart Failure
por: Batool, Aisha, et al.
Publicado: (2021)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020)

Paradox of telemedicine: building or neglecting trust and equity
por: Yee, Vivian, et al.
Publicado: (2022)

Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
por: Agarwal, Rajiv, et al.
Publicado: (2020)

The calcium paradox - What should we have to fear?
por: de Oliveira, Marcos Aurélio Barboza, et al.
Publicado: (2014)

Tissue transglutaminase in the pathogenesis of heart failure
por: Shinde, Arti V., et al.
Publicado: (2017)

Prebiotic plausibility and networks of paradox-resolving independent models
por: Benner, Steven A.
Publicado: (2018)

Improving Prognosis Estimation in Patients with Heart Failure and the Cardiorenal Syndrome
por: Abdel-Qadir, Husam M., et al.
Publicado: (2011)

New roles for renin and prorenin in heart failure and cardiorenal crosstalk
por: Schroten, Nicolas F., et al.
Publicado: (2011)

Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction
por: Lazzeri, Chiara, et al.
Publicado: (2011)

Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure
por: Vinod, Poornima, et al.
Publicado: (2017)

Future collapse: how optimistic should we be?
por: Ehrlich, Paul R., et al.
Publicado: (2013)

Relaxin, a pleiotropic vasodilator for the treatment of heart failure
por: Teichman, Sam L., et al.
Publicado: (2008)

The mitral paradox of choice
por: Velu, J. F., et al.
Publicado: (2019)

Which criteria should we use to end isolation in hemodialysis patients with COVID-19?
por: Alfano, Gaetano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qtpr39lck7bcd526guesn5kbrk